HTA Secrets Unlocked
An insightful webinar examining health technology assessment (HTA) agency behavior and key insights to consider when seeking reimbursement, including:
- After regulatory approval, which HTA agency frequently issues decisions first?
- Are orphan drugs recommended more often than non-orphan drugs?
- For which agencies are orphan drug dossier requirements different than non-orphan drugs?
- Do patient/professional submissions matter in gaining reimbursement?